With the Sept. 30 deadline nearing for the public release of Sunshine Act information, providers and health-care attorneys are growing less confident of the accuracy of the data and the overall efficiency of the Open Payments program, industry stakeholders say.
A spokeswoman for the American Medical Association told Bloomberg BNA Aug. 4 that physicians are having a hard time reviewing and disputing potentially inaccurate payment data about them that has been provided to the Centers for Medicare & Medicaid Services by pharmaceutical companies and group purchasing organizations (GPOs).
Physicians have until Aug. 27 to dispute any inaccurate data, and “we ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.